By analyzing PHD2 and EGFR expression in TMAs of tumor biopsies from 313 human breast cancer patients, we found that PHD2 showed a positive and significant correlation to EGFR expression (correlation coefficient = 0.231, p<0.001; n=313). This evidence concerns the gene EGLN1 and neoplasm.